• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机程序LUDI:一种全新的酶抑制剂从头设计方法。

The computer program LUDI: a new method for the de novo design of enzyme inhibitors.

作者信息

Böhm H J

机构信息

BASF AG, Central Research, Ludwigshafen, Germany.

出版信息

J Comput Aided Mol Des. 1992 Feb;6(1):61-78. doi: 10.1007/BF00124387.

DOI:10.1007/BF00124387
PMID:1583540
Abstract

A new computer program is described, which positions small molecules into clefts of protein structures (e.g. an active site of an enzyme) in such a way that hydrogen bonds can be formed with the enzyme and hydrophobic pockets are filled with hydrophobic groups. The program works in three steps. First it calculates interaction sites, which are discrete positions in space suitable to form hydrogen bonds or to fill a hydrophobic pocket. The interaction sites are derived from distributions of nonbonded contacts generated by a search through the Cambridge Structural Database. An alternative route to generate the interaction sites is the use of rules. The second step is the fit of molecular fragments onto the interaction sites. Currently we use a library of 600 fragments for the fitting. The final step in the present program is the connection of some or all of the fitted fragments to a single molecule. This is done by bridge fragments. Applications are presented for the crystal packing of benzoic acid and the enzymes dihydrofolate reductase and trypsin.

摘要

本文描述了一种新的计算机程序,该程序可将小分子定位到蛋白质结构的裂隙中(如酶的活性位点),使得小分子能够与酶形成氢键,并且疏水口袋被疏水基团填充。该程序分三步运行。首先,它计算相互作用位点,这些位点是空间中适合形成氢键或填充疏水口袋的离散位置。相互作用位点源自通过搜索剑桥结构数据库生成的非键接触分布。生成相互作用位点的另一种途径是使用规则。第二步是将分子片段拟合到相互作用位点上。目前我们使用一个包含600个片段的库进行拟合。本程序的最后一步是将部分或全部拟合片段连接成单个分子。这通过桥连片段来完成。文中展示了该程序在苯甲酸晶体堆积以及二氢叶酸还原酶和胰蛋白酶等酶方面的应用。

相似文献

1
The computer program LUDI: a new method for the de novo design of enzyme inhibitors.计算机程序LUDI:一种全新的酶抑制剂从头设计方法。
J Comput Aided Mol Des. 1992 Feb;6(1):61-78. doi: 10.1007/BF00124387.
2
LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads.
J Comput Aided Mol Des. 1992 Dec;6(6):593-606. doi: 10.1007/BF00126217.
3
A novel computational tool for automated structure-based drug design.一种用于基于结构的自动化药物设计的新型计算工具。
J Mol Recognit. 1993 Sep;6(3):131-7. doi: 10.1002/jmr.300060305.
4
FlexE: efficient molecular docking considering protein structure variations.FlexE:考虑蛋白质结构变异的高效分子对接
J Mol Biol. 2001 Apr 27;308(2):377-95. doi: 10.1006/jmbi.2001.4551.
5
Flexibases: a way to enhance the use of molecular docking methods.柔性底座:一种增强分子对接方法应用的途径。
J Comput Aided Mol Des. 1994 Oct;8(5):565-82. doi: 10.1007/BF00123666.
6
Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation.
J Med Chem. 1993 Oct 1;36(20):2921-8. doi: 10.1021/jm00072a011.
7
RASSE: a new method for structure-based drug design.RASSE:一种基于结构的药物设计新方法。
J Chem Inf Comput Sci. 1996 Nov-Dec;36(6):1187-94. doi: 10.1021/ci950277w.
8
Consideration of the pH-dependent inhibition of dihydrofolate reductase by methotrexate.对甲氨蝶呤对二氢叶酸还原酶的pH依赖性抑制作用的考量。
J Mol Biol. 1997 Aug 29;271(4):656-68. doi: 10.1006/jmbi.1997.1173.
9
PRO_LIGAND: an approach to de novo molecular design. 6. Flexible fitting in the design of peptides.
J Comput Aided Mol Des. 1995 Oct;9(5):381-95. doi: 10.1007/BF00123996.
10
X-SITE: use of empirically derived atomic packing preferences to identify favourable interaction regions in the binding sites of proteins.X-SITE:利用经验推导的原子堆积偏好来识别蛋白质结合位点中的有利相互作用区域。
J Mol Biol. 1996 May 31;259(1):175-201. doi: 10.1006/jmbi.1996.0311.

引用本文的文献

1
Rag2Mol: structure-based drug design based on retrieval augmented generation.Rag2Mol:基于检索增强生成的基于结构的药物设计。
Brief Bioinform. 2025 May 1;26(3). doi: 10.1093/bib/bbaf265.
2
Moldrug algorithm for an automated ligand binding site exploration by 3D aware molecular enumerations.用于通过3D感知分子枚举自动探索配体结合位点的Moldrug算法。
J Cheminform. 2025 May 26;17(1):85. doi: 10.1186/s13321-025-01022-3.
3
Molecular Dynamics (MD) Simulation of GPR87-LPA Binding: Therapeutic Implications for Targeted Cancer Treatment.

本文引用的文献

1
Crystallographic R factor refinement by molecular dynamics.利用分子动力学进行晶体学 R 因子精修。
Science. 1987 Jan 23;235(4787):458-60. doi: 10.1126/science.235.4787.458.
2
Stereochemistry of polypeptide chain configurations.多肽链构型的立体化学
J Mol Biol. 1963 Jul;7:95-9. doi: 10.1016/s0022-2836(63)80023-6.
3
Solvent-accessible surfaces of proteins and nucleic acids.蛋白质和核酸的溶剂可及表面。
GPR87与溶血磷脂酸(LPA)结合的分子动力学(MD)模拟:对靶向癌症治疗的治疗意义
Anticancer Agents Med Chem. 2025 Apr 9. doi: 10.2174/0118715206374428250403103159.
4
Decoding Drug Discovery: Exploring A-to-Z In Silico Methods for Beginners.解码药物发现:为初学者探索从A到Z的计算机模拟方法。
Appl Biochem Biotechnol. 2025 Mar;197(3):1453-1503. doi: 10.1007/s12010-024-05110-2. Epub 2024 Dec 4.
5
Computer-aided Drug Discovery Approaches in the Identification of Anticancer Drugs from Natural Products: A Review.从天然产物中鉴定抗癌药物的计算机辅助药物发现方法:综述
Curr Comput Aided Drug Des. 2025;21(1):1-14. doi: 10.2174/0115734099283410240406064042.
6
The AI-driven Drug Design (AIDD) platform: an interactive multi-parameter optimization system integrating molecular evolution with physiologically based pharmacokinetic simulations.人工智能驱动的药物设计 (AIDD) 平台:一个集成分子进化与基于生理的药代动力学模拟的交互式多参数优化系统。
J Comput Aided Mol Des. 2024 Mar 19;38(1):14. doi: 10.1007/s10822-024-00552-6.
7
Lead Identification Through Studies: Targeting Acetylcholinesterase Enzyme Against Alzheimer's Disease.通过研究进行先导物鉴定:针对阿尔茨海默病的乙酰胆碱酯酶靶点。
Cent Nerv Syst Agents Med Chem. 2024;24(2):219-242. doi: 10.2174/0118715249268585240107184956.
8
Computational fragment-based drug design of potential Glo-I inhibitors.基于片段的潜在 Glo-I 抑制剂的计算药物设计。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2301758. doi: 10.1080/14756366.2024.2301758. Epub 2024 Jan 22.
9
Applications of machine learning in computer-aided drug discovery.机器学习在计算机辅助药物发现中的应用。
QRB Discov. 2022 Sep 1;3:e14. doi: 10.1017/qrd.2022.12. eCollection 2022.
10
Computational approaches streamlining drug discovery.计算方法简化药物发现。
Nature. 2023 Apr;616(7958):673-685. doi: 10.1038/s41586-023-05905-z. Epub 2023 Apr 26.
Science. 1983 Aug 19;221(4612):709-13. doi: 10.1126/science.6879170.
4
Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate.大肠杆菌和干酪乳杆菌二氢叶酸还原酶的晶体结构在1.7埃分辨率下的精修。I. 甲氨蝶呤的一般特征和结合情况
J Biol Chem. 1982 Nov 25;257(22):13650-62.
5
[Synthetic inhibitors of serine proteinases. Part 25: Inhibition of trypsin, plasmin and thrombin by amides of N alpha-substituted amidinophenylalanines and 3-amidinophenyl-3-aminopropionic acids (author's transl)].[丝氨酸蛋白酶的合成抑制剂。第25部分:Nα-取代脒基苯丙氨酸和3-脒基苯基-3-氨基丙酸的酰胺对胰蛋白酶、纤溶酶和凝血酶的抑制作用(作者译)]
Pharmazie. 1981 Sep;36(9):639-41.
6
Irreversible enzyme inhibitors. CVI. Proteolytic enzymes. I. Bulk tolerances in trypsin-inhibitor complexes.不可逆酶抑制剂。CVI. 蛋白水解酶。I. 胰蛋白酶抑制剂复合物中的整体耐受性。
J Med Chem. 1967 Nov;10(6):1123-8. doi: 10.1021/jm00318a030.
7
A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.一种用于确定生物学上重要大分子上能量有利结合位点的计算程序。
J Med Chem. 1985 Jul;28(7):849-57. doi: 10.1021/jm00145a002.
8
A method for fast energy estimation and visualization of protein-ligand interaction.
J Comput Aided Mol Des. 1987 Oct;1(3):197-210. doi: 10.1007/BF01677044.
9
Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure.利用形状互补性作为初步筛选方法,来设计针对已知三维结构受体结合位点的配体。
J Med Chem. 1988 Apr;31(4):722-9. doi: 10.1021/jm00399a006.
10
Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system.配体与蛋白质结合的结构和能量学:大肠杆菌二氢叶酸还原酶 - 甲氧苄啶,一种药物 - 受体系统。
Proteins. 1988;4(1):31-47. doi: 10.1002/prot.340040106.